Cargando…

Impact of Corporate Governance on Research and Development Investment in the Pharmaceutical Industry in South Korea

OBJECTIVES: The purpose of this study is to analyze the influence of the corporate governance of pharmaceutical companies on research and development (R&D) investment. METHODS: The period of the empirical analysis is from 2000 to 2012. Financial statements and comments in general, and internal t...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lee, Munjae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korea Centers for Disease Control and Prevention 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588441/ https://www.ncbi.nlm.nih.gov/pubmed/26473092 http://dx.doi.org/10.1016/j.phrp.2015.07.003

Ejemplares similares

Analysis on Time-Lag Effect of Research and Development Investment in the Pharmaceutical Industry in Korea
por: Lee, Munjae, et al.
Publicado: (2015)

The Determinants of Research and Development Investment in the Pharmaceutical Industry: Focus on Financial Structures
por: Lee, Munjae, et al.
Publicado: (2015)

Corporate social responsibility of pharmaceutical industry in Korea
por: Bae, Green, et al.
Publicado: (2022)

Corporate Sustainability Development Strategy and Corporate Environmental Governance—The Moderating Role of Corporate Environmental Investments
por: Ao, Xiangyuan, et al.
Publicado: (2023)

Industry Competition, Corporate Governance, and Voluntary Disclosure of Greenhouse Gas Emissions Information: Evidence from South Korea
por: Lee, Hyunah, et al.
Publicado: (2022)

Transnational corporations in the pharmaceutical industry of developing countries.
Publicado: (1984)

Corporate investment and government policy during the COVID-19 crisis
por: Hoang, Khanh, et al.
Publicado: (2022)

Public preferences for corporate social responsibility activities in the pharmaceutical industry: Empirical evidence from Korea
por: Lee, Hankil, et al.
Publicado: (2019)

Corporate digital transformation and strategic investments of construction industry in China
por: Zhu, Zhuohui, et al.
Publicado: (2023)

Strategies for Promoting the Medical Device Industry in Korea: An Analytical Hierarchy Process Analysis
por: Lee, Munjae
Publicado: (2018)

Commentary: Reconsidering Pharmaceutical Research and Development Investments
por: Gagnon, Marc-André
Publicado: (2023)

The Impact of Compensation Gap on Corporate Innovation: Evidence from China’s Pharmaceutical Industry
por: Fu, Liping, et al.
Publicado: (2022)

Corporate environmental governance scheme and investment efficiency over the course of COVID-19
por: Liu, Haiyue, et al.
Publicado: (2022)

Corporate governance in development : the experiences of Brazil, Chile, India, and South Africa /
Publicado: (2003)

Revealing the Effects of Corporate Governance on Green Investment and Innovation: Do Law and Policy Matter?
por: Lai, Yuan, et al.
Publicado: (2022)

Factors influencing the health satisfaction of users of public health and medical institutions in South Korea
por: Yoon, Kichan, et al.
Publicado: (2023)

Pharmaceutical industry representation on CIHR’s governing council
por: Ghali, William, et al.
Publicado: (2010)

Corporate governance
por: Johnson, Don
Publicado: (2017)

Corporate governance
por: Sarkis, Joseph, et al.
Publicado: (2016)

Corporate governance
por: Monks, Robert A G, et al.
Publicado: (2011)

Financial Analysis of National University Hospitals in Korea
por: Lee, Munjae
Publicado: (2015)

Corporate Competing Culture and Environmental Investment
por: Tian, Jinfang, et al.
Publicado: (2022)

The Pharmaceutical Industry and the Canadian Government: Folie à Deux
por: Lexchin, Joel
Publicado: (2017)

Competitive Strategy for Successful National University Hospital Management in the Republic of Korea
por: Lee, Munjae
Publicado: (2016)

How Should the Social Service Quality Evaluation in South Korea Be Verified? Focusing on Community Care Services
por: Yoon, Kichan, et al.
Publicado: (2020)

Corporate Governance Matters
por: Larcker, David, et al.
Publicado: (2020)

Corporate Governance in Action
por: Engwall, Lars
Publicado: (2017)

The Impact of China’s ETS on Corporate Green Governance Based on the Perspective of Corporate ESG Performance
por: Yao, Riquan, et al.
Publicado: (2023)

Analyzing the Effectiveness of Data-Linked Projects for Health Promotion in Public Health Centers of South Korea
por: Yoon, Kichan, et al.
Publicado: (2023)

Corporate valuation for portfolio investment: analyzing assets, earnings, cash flow, stock price, governance, and special situations
por: Monks, Robert A G, et al.
Publicado: (2011)

The link between corporate sustainability and willingness to invest: new evidence from the field of ethical investments
por: Lingnau, Volker, et al.
Publicado: (2022)

The challenge of institutionalised complicity: Researching the pharmaceutical industry in the era of impact and engagement
por: Martin, Paul A.
Publicado: (2022)

Necropolitical Governance and State-Corporate Harms: COVID-19 and the U.S. Pork Packing Industry
por: Ken, Ivy, et al.
Publicado: (2022)

The impact of corporate culture on industrial accidents in high-risk industries: a cross-sectional survey
por: NOH, Jooman, et al.
Publicado: (2022)

Individual corporate reputation and perception of collective corporate reputation regarding stock market investments
por: Blajer-Gołębiewska, Anna
Publicado: (2021)

Multinational Pharmaceutical Companies Shortchange Canada in Research and Development Investments: Is It Time to Pursue Other Options?
por: Lee, Shoo K., et al.
Publicado: (2023)

Pharmaceutical Industry’s Engagement in the Global Equitable Distribution of COVID-19 Vaccines: Corporate Social Responsibility of EUL Vaccine Developers
por: Sung, Meekang, et al.
Publicado: (2021)

The impact of corporate governance on financial performance: a cross-sector study
por: Affes, Wajdi, et al.
Publicado: (2023)

IT governance: implementing frameworks and standards for the corporate governance of IT
por: Calder, Alan, et al.
Publicado: (2009)

Corporate governance and corporate behavior in Japan: the consequences of stock options and corporate diversification
por: Hanazaki, Masaharu
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e30q83g27cmojm8hpont3md33c